OpenAI acquires Orchestra Bio, bringing its drug-development coordination platform and team together with Rosalind to build agents for biopharma workflows.

Published
OpenAI ↗ · Source dated
—

Published
OpenAI ↗ · Source dated
OpenAI chief scientist Jakub Pachocki wants rival labs to agree on when to pause AI training.
Treasury Secretary Questions Jensen Huang's Role Amid Compliance Inquiry
China plans standards for how AI providers count tokens, bill customers and measure service quality, National Data Administration chief Liu Liehong said Nov.
Tesla's AI4 Computer Cost Doubles Due to Memory Price Hikes
Trump Advocates for Older Chips in U.S.-China Tech Sales
Bessent Defends Chip Rules Amid China De-risking Talks
Checking account…
Loading comments…